Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors by Pi, Xinchun et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: ARTICLE
© The Rockefeller University Press    $30.00
The Journal of Cell Biology, Vol. 179, No. 7, December 31, 2007 1569–1582
http://www.jcb.org/cgi/doi/10.1083/jcb.200704010
JCB 1569
Introduction
The bone morphogenetic proteins (BMPs) play important roles 
in cellular processes such as proliferation, differentiation, motility, 
adhesion, cell death, and the specifi  cation of cell fate during em-
bryogenesis (Hogan, 1996; Zhang and Bradley, 1996; Massague, 
1998; Wozney, 2002). Both in vitro and in vivo assays indi-
cate that assembly of new blood vessels via vasculogenesis and 
angiogenesis depends on BMP signaling via direct effects on 
endothelial cells (Yamashita et al., 1997; Moutsatsos et al., 2001; 
Valdimarsdottir et al., 2002). For example, BMP2 stimulates 
  endothelial proliferation, migration, and tube formation during 
tumor neovascularization (Raida et al., 2005), and our laboratory 
recently reported that BMP6 enhances in vitro angiogenesis via 
cyclooxygenase 2–dependent prostanoid generation (Ren et al., 
2007). Similarly, mice null for Smad5, a transcriptional activator 
of BMP responses, die between days 10.5 and 11.5 of gestation 
as a result of defective vascular   development typifi  ed by abnormal 
vasculature and irregularly distributed blood cells in the yolk sac 
(Yang et al., 1999). Collectively, these data support a model in which 
BMPs critically regulate angiogenesis and embryonic develop-
ment under diverse circumstances.
There are two mechanistically distinct types of angio-
genesis: sprouting angiogenesis and nonsprouting angiogenesis 
(also called intussusception; Folkman and Klagsbrun, 1987; 
Klagsbrun and D’Amore, 1991; Patan et al., 1996). Intussus-
ception occurs by the proliferation of endothelial cells within 
a vessel and the formation of a large lumen that splits by the 
insertion of tissue columns into vessels (Patan, 2000). In the 
case of sprouting angiogenesis, migration of existing endothelial 
cells is critical for new vessel formation. In angiogenic exten-
sions in the brain, endothelial cells at the tip of the sprout de-
velop fi  liform processes (Klosovskii and Zhukova, 1963). There 
is evidence from previous studies that endothelial sprouts can 
extend multiple fi  lopodia at their distal tips (Bar and Wolff, 
1972; Marin-Padilla, 1985), indicating that growing vascular 
sprouts are endowed with specialized tip structures with poten-
tial functions in guidance and migration. Filopodia and related 
structures such as microspikes, cytonemes, and microvilli are thin 
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ndothelial cell migration is an important step during 
angiogenesis, and its dysregulation contributes to 
aberrant neovascularization. The bone morpho-
genetic proteins (BMPs) are potent stimulators of cell migra-
tion and angiogenesis. Using microarray analyses, we 
ﬁ  nd that myosin-X (Myo10) is a BMP target gene. In endo-
thelial cells, BMP6-induced Myo10 localizes in ﬁ  lopodia, 
and BMP-dependent ﬁ  lopodial assembly decreases when 
Myo10 expression is reduced. Likewise, cellular alignment 
and directional migration induced by BMP6 are Myo10 
dependent. Surprisingly, we ﬁ  nd that Myo10 and BMP6 
receptor ALK6 colocalize in a BMP6-dependent fashion. 
ALK6 translocates into ﬁ  lopodia after BMP6 stimulation, 
and both ALK6 and Myo10 possess intraﬁ  lopodial motility. 
Additionally, Myo10 is required for BMP6-dependent 
Smad activation, indicating that in addition to its function 
in ﬁ  lopodial assembly, Myo10 also participates in a req-
uisite ampliﬁ  cation loop for BMP signaling. Our data indi-
cate that Myo10 is required to guide endothelial migration 
toward BMP6 gradients via the regulation of ﬁ  lopodial 
function and ampliﬁ  cation of BMP signals.
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Figure 1.  Myo10 is up-regulated by BMP2 and BMP6 treatment. (A) Microarray analysis was performed with RNA samples puriﬁ  ed from MECs treated 
with BMP2, BMP6, or DMSO for 4 h (Ren et al., 2007). Differentially expressed genes were selected with a p-value ≤0.05 and ratio fold change ≥±1.5 
and were subjected to hierarchical cluster analysis. Median-centered clusters were viewed with JavaTreeView. Fold change relative to common reference 
is indicated by red (+1.5; full scale) and green (−1.5; full scale) intensity. This image is a group of clustered genes with selected genes labeled. (B) MECs 
were treated with BMP2 and BMP6, and the total RNA was used for RT-PCR analysis with Myo10-speciﬁ  c primers. Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was used as an internal control. (C) RT-PCR analysis of Myo10 transcripts after BMP6 treatment for the indicated times. (D) Western blotting 
analysis of Myo10 protein expression after BMP6 treatment for the indicated times. (E) Western blotting analysis of Myo10 protein expression after BMP6 
treatment for 8 h with the indicated dosages. (F–I) Myo10 is up-regulated by BMP6 and VEGF but not by S1P and FGF-2 treatment. (F–H) MECs were 
treated with VEGF (F), S1P (G), and FGF2 (H) for the indicated times. The cell lysates were subjected to Western blotting analysis of Myo10 protein MYOSIN-X IN BMP-GUIDED ENDOTHELIAL MIGRATION • PI ET AL. 1571
cylindrical extensions of the cell membrane that are fi  lled with 
long actin fi  laments organized as a tight bundle with their 
barbed ends (fast growing ends) pointing toward the direction 
of protrusion (Small, 1988). Filopodia are used by many cell 
types as sensing organs to explore the extracellular matrix and 
surface of other cells. However, the role of filopodia in di-
rected endothelial migration and sprouting angiogenesis is still 
a   mystery and receives little notice in today’s concepts of vas-
cular development.
Because the mechanisms by which BMPs induce angio-
genesis are still poorly understood and the molecular players 
responsible for the initiation of endothelial migration and sub-
sequent new blood vessel formation are not clear, we performed 
gene expression profi  le analysis of the BMP6-mediated signaling 
network in endothelial cells. Myosin-X (Myo10), an unconven-
tional myosin critical for fi  lopodial formation (Bohil et al., 2006), 
was induced by BMP2 and BMP6 in these studies. Specialized 
fi  lopodia known as cytonemes in Drosophila melanogaster 
orient along a decapentaplegic (orthologue of BMP) gradient 
(Hsiung et al., 2005), and long fi  lopodia extending from tip 
endothelial cells under the guidance of VEGF-A are required for 
early postnatal retina vasculature formation (Gerhardt et al., 2003). 
Because of this, we hypothesized that BMPs might stimulate 
fi  lopodial formation and directed migration in endothelial cells 
and that up-regulation of Myo10 is a critical cue for the endo-
thelium when probing the local environment during blood vessel 
assembly is required.
Results
Identiﬁ  cation of Myo10 as a BMP target 
gene in endothelial cells
To better understand the mechanistic roles of BMPs in angio-
genesis, we identifi  ed candidate BMP-responsive genes in endo-
thelial cells using microarray technology. Total RNA samples 
were extracted from mouse intraembryonic endothelial cells 
(MECs) untreated or treated with BMP2 or BMP6 for 4 h. 
Among the regulated genes, Myo10 was up-regulated in cells 
treated with either BMP2 or BMP6 (Fig. 1 A). The up-regulation of 
Myo10 by BMP2 and BMP6 was confi  rmed at both the mRNA 
and protein levels. RT-PCR analysis indicated that Myo10 RNA 
levels increased dramatically after 100 ng/ml BMP2 or BMP6 
treatment for 4 h in MECs (Fig. 1 B). Peak induction of Myo10 
after BMP6 treatment occurred at 4 h for Myo10 mRNA and 
at 8 h for Myo10 protein (Fig. 1, C and D). The induction of 
Myo10 protein by BMP6 occurred in a dose-dependent fashion 
(Fig. 1 E). A similar increase in Myo10 protein level was also 
detected in human endothelial cells treated with BMP6 (unpub-
lished data). Based on these results, 8-h treatment of 100 ng/ml 
BMP6 was used in the following experiments unless other-
wise stated. To determine whether Myo10 could also be induced 
by other angiogenic factors, we stimulated MECs with VEGF, 
sphingosine-1–phosphate (S1P), and FGF-2. None of these fac-
tors were able to induce the level of Myo10 production seen 
with BMP6 stimulation; there was a modest increase in Myo10 
protein levels associated with VEGF treatment (Fig. 1 F) but 
almost no change seen with either S1P or FGF-2 (Fig. 1, G and H). 
This comparison of BMP6 to other angiogenic factors (Fig. 1 I) 
supports the hypothesis that Myo10 is a relatively BMP-specifi  c 
target gene.
Using immunofl  uorescence staining, we found that BMP6 
treatment qualitatively increased the number of fi  lopodial ex-
tensions in MECs (Fig. 2; compare G–I with the untreated cells 
in D–F). In addition, BMP6 stimulation induced the localization 
of Myo10 into fi  lopodial projections of MECs (Fig. 2, compare 
H with E). The staining of Myo10 in the cytoplasm of BMP6-
treated cells (Fig. 2 H) indicated the expression of Myo10 in the 
cytosol compartment, which might represent the protein pool 
of Myo10 available for translocation into fi  lopodia when fi  lo-
podial assembly is needed. The images stained with control IgG 
(Fig. 2 B) demonstrated the specifi  city of the anti-Myo10 poly-
clonal antibody. In addition, we found that overexpressed GFP-
tagged Myo10 protein in MECs induced marked changes in 
MEC morphology (including a dramatic increase in the number 
of fi  lopodia) even in the absence of BMP6 stimulation, and 
GFP-Myo10 specifi  cally localized within fi  lopodial extensions 
(Fig. 2 K). These data indicate that BMP6 stimulation induces 
fi  lopodial extensions into which Myo10 localizes and that in-
creased expression of Myo10 alone is able to direct fi  lopodial 
assembly in the absence of external cues. These observations 
suggested a fundamental role for Myo10 in the mechanistic 
events that are required for BMP-dependent vessel formation and 
prompted us to explore this relationship further.
Requirement of Myo10 for BMP6-
dependent ﬁ  lopodial assembly
To test the functional role of Myo10 in MECs, we knocked 
down the expression of endogenous Myo10 by siRNA gener-
ated with a plasmid system that also coexpressed GFP from a 
second locus within the vector so that transfection could be 
monitored at the single-cell level. Among the four different 
siRNAs tested, Myo10-siRNA1 and Myo10-siRNA2 signifi  cantly 
decreased Myo10 protein levels (Fig. 3 A). Given that our trans-
fection effi  ciency of MECs was ~40%, we surmise that Myo10 
mRNA was suppressed by ≥80% by these siRNAs after BMP6 
stimulation. Immunofl  uorescence analyses further confi  rmed 
that Myo10 siRNA1 and Myo10 siRNA2 effi  ciently knocked 
down Myo10 expression induced by BMP6 in transfected cells 
compared with untransfected cells or control siRNA-transfected 
cells (unpublished data).
To quantitatively assess the effects of BMP6 on fi  lopodial 
extension and the role of endogenous Myo10 in this process, 
high resolution imaging with correlative fl  uorescent scanning EM 
(SEM) was performed (Bohil et al., 2006). MECs transfected 
  expression and actin as the internal control. (I) Comparison of Myo10 expression level after BMP6, VEGF, S1P, and FGF-2 treatment. The band intensity 
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with GFP-expressing Myo10 siRNA plasmids were   cultured on 
etched grid coverslips to localize the transfected cells. The cells 
were then treated with BMP6 for 8 h and processed for SEM imag-
ing (Fig. 3, B–H). BMP6 treatment increased fi  lopodial number on 
the cell surface (from 14 ± 9 to 59 ± 17). The majority of BMP6-
induced fi  lopodia were substrate-attached fi  lopodia (Fig. 3 E); 
thus, we tested whether or not there was a substrate-specifi  c ef-
fect of fi  lopodial formation or attachment by growing cells on 
collagen- and fi  bronectin-coated dishes. No difference was seen 
between the different substrates, (unpublished data) and so, for 
the remainder of our experiments, we used collagen as the adhe-
sion factor unless otherwise stated. Formation of fi  lopodia after 
BMP6 stimulation was almost completely suppressed by Myo10 
siRNA1 and Myo10 siRNA2 (from 59 ± 17 to 19 ± 9 or 20 ± 10; 
Fig. 3, F and G). It has been shown previously that Myo10 can 
stimulate the assembly of fi  lopodial processes (Bohil et al., 2006), 
although the precise physiologic context for these events has 
not been clear. These data support a requisite physiological role 
for Myo10 in fi  lopodial formation induced by BMP6 in endo-
thelial cells. BMP6 increased fi  lopodia number in endothelial 
cells (Fig. 3, B–H) but did not further enhance the fi  lopodial 
formation induced by the overexpression of Myo10 (not depicted). 
It was previously suggested that Myo10 functions downstream 
of Cdc42 for formation of the fi  lopodial extensions. In the study 
performed by Bohil et al. (2006), Myo10 siRNA inhibited the 
fi  lopodial extensions increased by constitutively active Cdc42, 
but dominant-negative Cdc42 did not inhibit fi  lopodia forma-
tion induced by Myo10 overexpression. However, when we per-
formed Cdc42 and Rac1 activity assays, we found that their 
activities were not increased by BMP6 treatment in   endothelial 
Figure 2.  Myo10 induced by BMP6 is localized in ﬁ  lopodia. 
MECs were treated with BMP6 for 8 h (A–C and G–I) 
or DMSO (D–F) and were ﬁ  xed with PFA. Cells were stained 
with phalloidin (A, D, G, J, and M) and chicken anti–mouse 
Myo10 pAb (E and H) or control IgG (B) as a negative 
control. Exogenous Myo10 (GFP tagged) was expressed 
by transiently transfecting MECs with a plasmid encoding 
GFP-Myo10 (J–L). GFP control plasmids (M–O) were trans-
fected in MECs as the negative controls for GFP-Myo10. 
Actin was visualized using Texas red–phalloidin (red). 
Myo10 was visualized using chicken anti-Myo10 pAb 
(green; E and H) or GFP (green; K and N). The arrows rep-
resent ﬁ  lopodia.MYOSIN-X IN BMP-GUIDED ENDOTHELIAL MIGRATION • PI ET AL. 1573
cells (unpublished data), suggesting that the basal activity of 
Cdc42 in endothelial cells might be strong enough to permit 
Myo10-mediated fi  lopodial formation induced by BMP6 and 
that the effects of BMP6 are not directly mediated through the 
activation of Cdc42.
Myo10 is critical for cell alignment toward 
a BMP gradient
To further test whether Myo10-dependent fi  lopodia act as sen-
sors in the directed cell movement regulated by BMP6, we used 
Dunn chamber assays. In these assays, a radially directed linear 
Figure 3.  Myo10 siRNAs inhibit BMP6-induced ﬁ  lopodia. (A) MECs transfected with Myo10 siRNAs were lysed and subjected to Western blotting analysis 
with anti-Myo10 pAb (top). A β-actin blot of the same membrane controlled for sample loadings (bottom). (B–H) Knockdown of endogenous Myo10 in 
MECs by Myo10 siRNAs decreased ﬁ  lopodial number in the BMP6-treated conditions. MECs were transfected with GFP-tagged Myo10 siRNA1 (C and F) 
or siRNA2 (D and G) or by the GFP-tagged control vector containing irrelevant siRNA sequence (B and E). Cells were treated with 100 ng/ml BMP6 (E–G) 
or DMSO (B–D) as a control, and GFP-positive cells were subjected for SEM analysis. (H) The bar graphs show quantiﬁ  cation of ﬁ  lopodial numbers in MECs 
transfected with GFP-tagged control siRNA, GFP-Myo10 siRNA1, or GFP-Myo10 siRNA2. *, P < 0.05; n = 3. n = 20 cells per sample.JCB • VOLUME 179 • NUMBER 7 • 2007  1574
diffusion gradient is established within 10–30 min that has a 
half-life of 10–30 h (Zicha et al., 1991). For our studies, MECs 
cultured on coverslips were pretreated with BMP6 for 4 h to 
induce the expression of Myo10 and fi  lopodia and were cul-
tured in the Dunn chamber for another 4 h to establish a directed 
BMP6 gradient. Cells were stained to identify nuclei (with DAPI) 
in combination with a Golgi marker (GM130) and fi  lamentous 
actin (phalloidin), which revealed the cell polarity and orienta-
tion of migration. Without BMP6 pretreatment or BMP6 gradi-
ent media, cells did not align toward any direction (Fig. 4 A). 
After either BMP6 pretreatment or establishment of a BMP6 
gradient, cells polarized but failed to align toward the BMP6 
gradient (Fig. 4, B and C). With BMP6 pretreatment plus cultur-
ing under conditions to establish a subsequent BMP6 gradient, 
cells unanimously aligned toward the BMP6 gradient (Fig. 4 D). 
These experiments indicate that both BMP6 pretreatment and 
the presence of a BMP6 gradient are necessary for cell reorien-
tation toward the gradient.
To determine whether induction of Myo10 by BMP6 dur-
ing the pretreatment period is required for directed cell polar-
ization, we knocked down Myo10 expression with Myo10 siRNA 
(Fig. 4, E–K). MECs transfected with control siRNA and pre-
treated with BMP6 for 4 h before application of the BMP6 gradi-
ent demonstrated increased alignment toward the BMP6 gradient 
(from 32 ± 10 to 95 ± 5%; Fig. 4 E). However, cells transfected 
with Myo10 siRNA1 under the same conditions demonstrated 
perturbed Golgi reorientation after the pretreatment of BMP6 
compared with similarly transfected cells without BMP6 pre-
treatment (from 32 ± 10 to 35 ± 8%; Fig. 4 F). Similarly, MECs 
expressing Myo10 siRNA2 also failed to align in the proper di-
rection (from 28 ± 7 to 27 ± 9%; Fig. 4 G). These knockdown 
cells (Fig. 4, F and G; arrowheads; and expressing GFP in I and J) 
are well controlled for by the nontransfected cells in the same 
images that do not express GFP, which still successfully reori-
ent toward the BMP6 gradient. These data strongly support a 
model in which Myo10 expression and consequent fi  lopodial 
assembly are required for endothelial cells to sense and respond 
to the guidance cue BMP6.
Role of Myo10 in BMP6-dependent 
directed migration of endothelial cells
To extend our observations, we performed assays to determine 
the importance of Myo10-dependent fi  lopodia formation in 
directed cell migration. Wound healing assays of MECs demon-
strated that BMP6 increased cell migration toward the wound 
area from 52.4 ± 6.5 to 81.3 ± 8.2% (Fig. 5 A). Myo10 induced 
by BMP6 was localized to the tip of fi  lopodia in endothelial cells 
on the leading edge of the wound compared with the cells without 
BMP6 treatment, as shown by immunofl  uorescence microscopy 
(Fig. 5, B and D). SEM images also demonstrated that more 
fi  lopodia formed on endothelial cells at the leading edge of the 
migration front after BMP6 treatment compared with control 
(Fig. 5, C and E).
To specifi  cally test the role of Myo10 in directed migration, 
we performed Boyden chamber assays to determine whether 
BMP-dependent directional migration is inhibited by Myo10 
knockdown with siRNA (Fig. 5 F). MECs were transfected with 
Myo10 siRNA1, Myo10 siRNA2, or control siRNA as indicated. 
Cells were then pretreated with BMP6 for 4 h and placed into 
Boyden chambers in the presence of a BMP6 gradient. BMP6 
pretreatment signifi  cantly increased directed cell migration in-
duced by the BMP6 gradient from 7 ± 2 to 52 ± 10 cells com-
pared with cells without BMP6 pretreatment (from 7 ± 2 to 18 ± 
14 cells). This increase in migration was inhibited by Myo10 
knockdown with Myo10 siRNA1 (from 52 ± 10 to 4 ± 2 cells) 
or Myo10 siRNA2 (from 52 ± 10 to 3 ± 5 cells), which indi-
cates that Myo10-mediated filopodial formation induced by 
BMP6 pretreatment is critical for BMP6-guided endothelial cell 
migration. Other angiogenic factors (VEGF, FGF-2, and S1P) 
were also able to induce directed cell migration; however, only 
the VEGF-induced migration was inhibited by disruption of 
fi  lopodia with Myo10 siRNA2 (Fig. S1, available at http://www
.jcb.org/cgi/content/full/jcb.200704010/DC1). The combined 
treatment of BMP6 and VEGF produced a small but not additive 
increase in migration compared with that seen with either drug 
on its own,  suggesting that BMP6 and VEGF do not work syn-
ergistically with each other.
Without a BMP6 gradient, cells pretreated with BMP6 also 
increased their migration in this assay, albeit to a lesser extent 
(from 7 ± 2 to 34 ± 9 cells). This suggested to us that increased 
fi  lopodia formation induced by BMP6 pretreatment also increased 
random cell migration in this assay even though cell reorien  tation 
fails to occur under these conditions. To test this hypo  thesis 
directly, we performed a random cell migration analysis using a 
live image recording system to monitor the speed and distance of 
cellular migration. BMP6 treatment increased the speed of endo-
thelial cell migration from 0.060 ± 0.016 to 0.146 ± 0.032 μm/min 
(Fig. S2 and Table S1). This effect was Myo10 dependent, as treat-
ment of cells with Myo10 siRNA2 decreased the speed of random 
migration to near control levels (0.070 ± 0.020 μm/min).
Role of Myo10 in BMP6-dependent 
tube formation
Endothelial cell migration is a critical step for tube formation 
during angiogenesis. To test the importance of Myo10 and fi  lo-
podia in higher order cell assembly processes, we examined the 
effect of Myo10 on the formation of capillary-like tubes formed 
in matrigel (Ren et al., 2007). MECs were transfected with 
Myo10 siRNA1, Myo10 siRNA2, or control siRNA. The next 
day, cells were serum starved for 1 h and plated on matrigel in 
medium containing 100 ng/ml BMP6. Treatment with BMP6 
signifi  cantly stimulated capillary-like structure formation at 6 h 
compared with cells without treatment (unpublished data): the 
cord length increased from 237 ± 41 to 783 ± 231 μm. In the 
Myo10 siRNA1–expressing cells, capillary-like structure forma-
tion was inhibited by  60.9%. Similarly, capillary-like structure 
formation was inhibited by  53.9% in Myo10 siRNA2–expressing 
cells. To exclude the possibility that the observed tube forma-
tion was merely a result of the matrigel environment in which 
the cells were plated, we performed a 3D collagen angiogenesis 
assay and verifi  ed that tubulogenesis did occur when endothe-
lial cells were treated for extended periods of time with BMP6 
(Fig. 5 J and Fig. S3, available at http://www.jcb.org/cgi/ content/
full/jcb.200704010/DC1) compared with cells without treatment MYOSIN-X IN BMP-GUIDED ENDOTHELIAL MIGRATION • PI ET AL. 1575
Figure 4.  Cell alignment is dependent on Myo10. (A–D) MECs aligned toward the BMP6 gradient. Cells cultured on the coverslips were pretreated with 
BMP6 (B and D) or DMSO (A and C) for 4 h, were transferred to the Dunn chamber with the media containing 0–200 ng/ml BMP6 gradient (C and D) or not 
containing gradient (A and B), and were maintained for 4 h. Cells were ﬁ  xed and stained with phalloidin, DAPI, and GM130. Actin (Texas red–phalloidin), 
red; Golgi (anti-GM130 mAb), green; nucleus (DAPI), blue. (E–K) Knockdown of endogenous Myo10 in MECs by Myo10 siRNAs inhibited cell alignment. 
(E–J) Cells were transfected with GFP-Myo10 siRNA1 or GFP-Myo10 siRNA2 and controlled by transfecting cells with GFP-tagged control vector containing 
irrelevant siRNA sequence. The cells were pretreated with BMP6 for 4 h and were transferred into the Dunn chamber for another 4 h with 0–200 ng/ml of the 
media containing BMP6 gradient. The cells were ﬁ  xed, and immunoﬂ  uorescent images were taken. GFP, green; Golgi (anti-GM130 mAb), red;   nucleus 
(DAPI), blue. White arrowheads represent the transfected cells with siRNAs (GFP positive). (K) Quantitative analysis of the aligned cells toward the higher 
BMP6 gradient. Error bars represent SD. n = 3; *, P < 0.05. n = at least 57 cells per sample. p.t., pretreatment.JCB • VOLUME 179 • NUMBER 7 • 2007  1576
Figure 5.  Myo10 knockdown inhibits directed cell migration and angiogenesis induced by BMP6. (A–E) BMP6 increased Myo10 proteins in ﬁ  lopodia, ﬁ  lo-
podial number, and directed migration. Wound-healing assay was performed with MECs grown on 35-mm wells. (A) The bar graph shows the recovered 
area after cells were stimulated with BMP6 for 16 h. (B and D) The immunoﬂ  uorescent staining of cells. Actin (Texas red–phalloidin), red; Myo10 (anti-
Myo10 pAb), green; overlay of the red and green, yellow. The increased yellow staining demonstrated the increased localization of Myo10 protein at the 
ﬁ  lopodial tips of the cells on the leading edge, where the ﬁ  lopodial number also increased. (C and E) The increase of ﬁ  lopodial number in SEM images of 
cells. Arrows represent the migration direction of the cells. IF, immunoﬂ  uorescence; SEM, scanning EM. (F) Myo10 knockdown inhibited directed cell migra-
tion induced by BMP6. MECs were transfected with GFP-Myo10 siRNA1, GFP-Myo10 siRNA2, or control siRNA, were pretreated with BMP6 for 4 h, and MYOSIN-X IN BMP-GUIDED ENDOTHELIAL MIGRATION • PI ET AL. 1577
(Fig. 5 G).  Tube formation was inhibited by 80.2% and 93.1% 
in the Myo10 siRNA1– and Myo10 siRNA2–expressing cells, 
respectively (Fig. 5, H, I, K, and L). Quantitative data are 
presented in Fig. 5 M. These data strongly indicate that Myo10 
and fi  lopodia are critical factors in endothelial cell migration 
and angiogenesis.
Association of Myo10 with the BMP 
receptor ALK6
The preceding experiments indicate that induction of Myo10 by 
BMP6 is required for BMP6-dependent fi  lopodial assembly, 
which, in turn, is required for endothelial cells to respond in a 
directed fashion to BMP6 gradients. This suggested to us that 
Myo10 might have additional roles in regulating BMP6 signal-
ing responses beyond its necessary role in inducing fi  lopodial 
processes on BMP-stimulated endothelial cells. Like most myo-
sins, the Myo10 heavy chain can be divided into three parts: 
head, neck, and tail. The head domain contains the motor activity. 
There are three IQ motifs in the neck region that are predicted 
to associate with calmodulin or a calmodulin-like light chain. 
The tail domain contains a coiled-coil domain, a PEST region, 
three pleckstrin homology domains, an MyTH4 domain, and 
a FERM domain (Sousa and Cheney, 2005). An interaction 
  between the Myo10 FERM domain and an NPXY motif within 
β-integrin cytoplasmic domains regulates integrin relocalization 
and the formation of substrate-attached fi  lopodia (Zhang et al., 
2004). To explore the possibility that Myo10 modulates BMP6 
signaling, we examined the localization of the BMP6 receptor 
ALK6 (expressed as a GFP fusion) in MECs stimulated with 
BMP6. Under these conditions, a fraction of ALK6 was local-
ized in fi  lopodia (Fig. 6 A). The ALK6-containing puncta moved 
from cytoplasm to fi  lopodia and possessed intrafi  lopodial motility 
(Fig. 6 and Video 1, available at http://www.jcb.org/cgi/content/
full/jcb.200704010/DC1). The mean rate of the forward move-
ments was  42 ± 16 nm s
−1 (n = 10 puncta). When coexpressed, 
ALK6 (tagged with HA) and GFP-Myo10 colocalized in the 
tips of fi  lopodia of BMP6-stimulated MECs (Fig. 6 B).
Based on this temporal and spatial colocalization, we 
tested the possibility of association between Myo10 and ALK6 
by coimmunoprecipitation. Overexpressed HA-ALK6 effi  ciently 
coimmunoprecipitated with GFP-Myo10 in 293T cells (Fig. 6 C), 
as did endogenous ALK6 and Myo10 in MECs (Fig. 6 D).   
Using time-lapse video microscopy, we observed the cotrans-
portation of Myo10 and ALK6, providing additional support that 
Myo10 and ALK6 move together within the fi  lopodia under 
certain circumstances (Video 2). However, we also observed 
some infrequent instances within fi  lopodia in which these two 
molecules appeared to move independently of each other, suggest-
ing that either the amount of Myo10 cotransporting with ALK6 
is below the detection limits under some circumstances or that 
there are other unknown Myo10-independent mechanisms for 
ALK6 transportation. In any event, these data support a model 
in which Myo10 binds to and is required for the transport of 
ALK6 to fi  lopodia, indicating that the association between Myo10 
and ALK6 likely plays important roles in coordinating fi  lopodial 
function and BMP signaling during directed endothelial cell 
migration and angiogenesis.
Myo10 is required for optimal 
intracellular responses to BMP stimulation 
in endothelial cells
We observed that Myo10 was not only required for BMP6-
 dependent  fi  lopodial assembly and consequent directed migra-
tion and angiogenesis of endothelial cells but also that the BMP 
receptor ALK6 was associated with Myo10 in fi  lopodia. This sug-
gested to us that Myo10 not only responds to BMP stimulation 
but might also be required for maximal BMP signal generation. 
It is known that BMPs transduce signals through trans-membrane 
serine-threonine kinase receptors, including type I and II receptors. 
Upon BMP-induced heteromeric complex formation, the con-
stitutively active serine/threonine kinse of the type II receptor 
phosphorylates type I receptor on its GS domain. The acti-
vated type I receptor phosphorylates regulatory Smads (Smad1, 
5, and 8). This phosphorylation of Smads by type I receptor is 
  inhibited by inhibitory Smads (Smad6 and 7). The association 
of regulatory Smads with common partner Smads (Smad4) leads 
to the translocation of heteromeric Smads to the nucleus and 
the activation of transcriptional machinery for BMP-responsive 
genes (ten Dijke et al., 2003). To test the involvement of Myo10 
in BMP6-transduced intracellular signaling events, we used 
Myo10 siRNA to knock down Myo10 protein to inhibit fi  lo-
podial assembly and the association between ALK6 and Myo10. 
In control cells, we observed that the major signaling down-
stream of BMP6 receptor ALK6 activation (specifi  cally, Smad1, 5, 
and 8 phosphorylation) was induced by BMP6 after 30 min of 
treatment and lasted for at least 8 h. Myo10 knockdown with 
Myo10 siRNA2 signifi  cantly inhibited the activation of Smads 
(Fig. 7). These experiments indicate that Myo10 is not only 
critical for fi  lopodial assembly but is also required for BMP6 
receptor–mediated endothelial activation by amplifying BMP 
responses, which mechanistically explains the important role 
of Myo10 in BMP6-induced directed migration of endothelial 
cells and angiogenesis.
Discussion
The major observation of this study is that Myo10 is critically 
important in a fi  lopodial sensor mechanism that mediates BMP6-
guided endothelial cell migration and angiogenesis. Specifi  cally, 
BMP6 potently induces Myo10 expression, and Myo10, in turn, 
is required for filopodial formation, cell alignment, directed 
migration, and tube formation induced by BMP6. Additionally, 
were trypsinized for the Boyden chamber assay. The cells migrating through the ﬁ  lter were counted. p.t., pretreatment. (G–M) Myo10 knockdown inhibited 
tube formation induced by BMP6 using 3D collagen assay. MECs were transfected with GFP-Myo10 siRNA1, GFP-Myo10 siRNA2, or control siRNA and 
were lysed for the 3D collagen angiogenesis assay. (G–L) The brightﬁ  eld images were taken after 24 h of incubation. (M) Quantitation of the tube formation. 
Error bars represent SD. n = 3; *, P < 0.05.JCB • VOLUME 179 • NUMBER 7 • 2007  1578
Myo10 associates with the BMP6 receptor ALK6 and modulates 
BMP6-dependent endothelial activation by regulating the phos-
phorylation of Smads, the direct downstream transcriptional 
targets of the BMP receptors. These experiments extend the pre-
vious observation that Myo10 induces nondirectional fi  lopodial 
formation (Bohil et al., 2006) and indicate that Myo10 serves as 
a critical integration node in growth factor signaling to facilitate 
directional probing of the local cellular environment as well as 
further amplifi  cation of growth factor signaling that is relevant to 
the pathophysiologically critical process of angiogenesis.
There is increasing evidence that secreted signaling mole-
cules within the BMP subfamily of the TGFβ superfamily are 
key regulators in the morphogenesis of multiple organ systems, 
including angiogenesis. VEGF and Id1 were among only a 
small number of identifi  ed downstream targets of BMPs re-
sponsible for vascular development and angiogenesis (Deckers 
et al., 2002; Valdimarsdottir et al., 2002) that was expanded by 
experiments from our laboratory that identifi  ed multiple tran-
scriptional targets of BMP2 and BMP6 in endothelium using 
microarray technology (Ren et al., 2007). A necessary role for 
Figure 6.  Myo10 interacts with ALK6. (A) Selected sequence from a time-lapse video focusing on the movements of puncta containing GFP-ALK6 proteins. 
Arrows represent the puncta containing GFP-ALK6. The images were taken every 30 s for 120 s after MECs were treated with BMP6 for 4 h. The mean 
rate of the forward movements for the puncta was  42 ± 16 nm s
−1 (n = 10 puncta). (B) Colocalization of exogenous GFP-tagged Myo10 and HA-tagged 
ALK6 at tips of ﬁ  lopodia in HeLa cells. Myo10 (GFP), green; ALK6 (anti-HA mAb), red. The arrow indicates colocalization. (C) Exogenous Myo10 associ-
ated with exogenous ALK6. GFP-Myo10 and HA-ALK6 were expressed in 293T cells, and immunoprecipitation was performed with anti-HA mAb followed 
by Western blotting against GFP. (D) Endogenous Myo10 associated with ALK6. MEC lysates were immunoprecipitated by anti-ALK6 mAb, with mouse IgG 
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cyclooxygenase 2–dependent prostanoid generation was identi-
fi  ed for BMP6-induced angiogenic responses through these 
inductive experiments (Ren et al., 2007). The identifi  cation of 
Myo10 as a BMP6-responsive gene expands the list of bona fi  de 
BMP targets in endothelium and begins to paint a picture of a 
co  ordinated program in which growth factors, intracellular signal-
ing pathways, and active structural processes are coordinated by 
BMPs to create new blood vessels.
Filopodia are best characterized in growth cones of mi-
grating axons that sample the external environment, searching 
for guidance cues that allow the growing axon to navigate over 
long distances and fi  nd appropriate targets (Tessier-Lavigne and 
Goodman, 1996). This study is the fi  rst to provide direct evidence 
indicating the physiological importance of Myo10 and fi  lopodia 
as sensors in directed endothelial migration and angiogenesis. 
Myo10 is known to induce the formation of nondirected dorsal 
fi  lopodia in a variety of cell types, including COS-7, HEK-293, 
and CAD cells when overexpressed (Bohil et al., 2006), as it 
does in MECs in our hands (unpublished data). However, our 
studies indicate that most of the fi  lopodia induced by BMP6 in 
MECs are substrate attached rather than dorsal projecting and 
unattached, yet these substrate-attached fi  lopodial are equally 
dependent on Myo10 for assembly in response to appropriate 
cues. These observations indicate that the role of Myo10 in fi  lo-
podial assembly in endothelial cells is more substantial than 
previous studies (Berg and Cheney, 2002; Bohil et al., 2006) 
suggest in that Myo10 is required for the guidance of fi  lopodial 
directionality that is triggered by gradients formed by growth 
factors such as BMP6. It seems that directed fi  lopodial assembly 
depends not only on increased levels of Myo10 but also on inte-
gration of other signals to create substrate-attached fi  lopodia. 
Whether the dorsal fi  lopodia induced by Myo10 overexpression 
alone represent an intermediate step in mature fi  lopodial assem-
bly or a terminal nonproductive architectural event remains to 
be determined; because β-integrin transportation by Myo10 to 
fi  lopodia stabilizes fi  lopodia by enhancing substrate attachment 
(Zhang et al., 2004), it seems most likely that dorsal fi  lopodia 
represent an intermediate state in physiologic fi  lopodial forma-
tion that may depend on integrin-dependent adhesive events for 
complete maturation to substrate attachment.
Myo10 contains an N-terminal motor domain, and the tail 
domains contain pleckstrin homology, MyTH4, and FERM mo-
tifs that are speculated to be the docking platform for its car-
goes, such as the β-integrins that bind to the FERM motif of 
Myo10 (Zhang et al., 2004). Our experiments support the ad-
dition of ALK6 to the list of Myo10 cargoes based on their co-
localization and the translocation of ALK6 from cytoplasmic 
regions into fi  lopodia along with Myo10 (Video 1). Notably, 
these observations are reminiscent of the report in Drosophila 
that the Decapentaplegic receptor Thickveins is present in dis-
crete bodies that move along fi  lopodia-like cytonemes (Hsiung 
et al., 2005). Although the primary localization of Myo10 is at 
the tips of fi  lopodia, puncta of Myo10 proteins are also visual-
ized along the fi  lopodia and in the cell body (Figs. 2 H and 6 B). 
Figure 7 .  Myo10 knockdown inhibits BMP6-induced Smad1, 5, and 8 activation. MECs were transfected with Myo10 siRNA2 or control siRNA and were 
stimulated with BMP6 for the indicated times for the activation of Smads. Cells were lysed for Western blotting analysis of the antiphospho-Smad1, 5, and 
8 pAb, anti-Smad5 pAb, and anti-Myo10 pAb. This is a representative image of three independent experiments.JCB • VOLUME 179 • NUMBER 7 • 2007  1580
Expression of Myo10 within the cytoplasm may indicate that 
pools of the protein are available for mobilization when fi  lopodial 
assembly is mandated by local cues. The mean rate of the for-
ward movements for puncta of GFP-ALK6 was  42 ± 16 nm s
−1 
(Fig. 6 A), which is similar to the rates of the forward move-
ments for GFP-Myo10 (84 ± 36 nm s
−1) reported previously 
(Berg and Cheney, 2002). The data that Myo10 and ALK6 move 
together within the fi  lopodia under certain circumstances fur-
ther support the critical role of Myo10 in the regulation of 
ALK6-transduced endothelial activation (Video 2). It raises the 
possibility that receptors for other growth factors also may use 
the Myo10 machinery to regulate the function of fi  lopodia for 
the perception of environmental cues.
There are two possible nonexclusive purposes for the as-
sociation of ALK6 with Myo10: these interactions may be re-
quired for fi  lopodial assembly and function, and, additionally, 
they may be required specifi  cally for proper BMP signaling. 
In support of the former role, ALK6-defi  cient mice have defects in 
axonal path fi  nding, which is analogous to the guidance and mi-
gration of endothelial cells (Liu et al., 2003). In addition, we have 
observed that confocal images of GFP-ALK6–overexpressing 
endothelial cells demonstrate increased fi  lopodial assembly 
(unpublished data). In support of a specifi  c role for Myo10–
ALK6 interactions in the regulation of BMP signaling, we ob-
served that the association of ALK6 and Myo10 is required for 
maximal BMP responses, indicating that Myo10 participates in 
an amplifi  cation loop for BMP signaling (Figs. 7 and 8). Con-
ceptually, this suggests that initial activation of BMP signaling 
in endothelial cells provokes the cell to up-regulate Myo10, ini-
tiating fi  lopodial assembly and BMP receptor transport to probe 
for additional BMP signaling cues.
Based on the results of the experiments here, we propose 
a model to explain how Myo10 induced by BMP6 contributes to 
BMP6-induced angiogenesis (Fig. 8). The activation of the BMP 
signaling pathway in endothelial cells leads to transcriptional 
  activation of Myo10 expression, which, in turn, increases the 
formation of fi  lopodia. Cell polarization ensues, provoking the 
initial steps in directed endothelial cell migration. As the BMP 
receptor ALK6 is translocated into fi  lopodia by Myo10, further 
increases in BMP signaling occur, providing positive feedback 
and a second level of control for endothelial cell activation. It is 
noteworthy that VEGF controls sprouting angiogenesis in the 
early postnatal retina by guiding fi  lopodial extensions of endo-
thelial tip cells (Gerhardt et al., 2003). Collectively, these obser-
vations and results of the present studies indicate that fi  lopodia 
may be a point of convergence for signaling pathways within 
endothelia and that maintenance of filopodial integrity is a 
  crucial determinant of the guidance of endothelial migration 
and angiogenesis.
Materials and methods
Reagents
Mouse Myo10 cDNA was cloned into EGFP-C1 Vector (Clontech Laborato-
ries, Inc.). ALK6 cDNA was provided by L. Attisano (University of Toronto, 
Toronto, Canada). Recombinant human BMP2, BMP6 protein, and anti-ALK6 
antibody were obtained from R&D Systems. Anti-pSmad1, 5, and 8 antibody 
and anti-Smad antibody were purchased from Cell Signaling Technology. 
Chicken anti-Myo10 polyclonal antibody was generated against the coiled-
coil region of mouse Myo10 protein (Sousa et al., 2006).
Cell culture and transfection
MECs were grown in DME supplemented with 10% FBS and antibiotics 
(100 U/ml penicillin and 68.6 mol/L streptomycin). The cells were cultured 
on glass coverslips precoated with 50 μg/ml collagen (Roche). For tran-
sient expression experiments,  50–70% conﬂ  uent MECs in 35-mm dishes 
were transfected 24 h after plating with 2 μg plasmids using 3 μl Lipo-
fectamine and 3 μl Plus reagent (Invitrogen) in DME without FBS and anti-
biotics. After 3 h of incubation, an equal volume of DME containing 20% 
FBS was added to the medium. 3 h later, the media were replaced with 
complete DME containing 10% FBS and antibiotics. 1 d later, cells were 
serum starved overnight and treated with BMP6.
Construction of siRNA
Sequences 1–4 for siRNA1–4, respectively, were chosen by Dharmacon 
software. Myo10 siRNA1 primers (5′-G  A  T  C  C  G  C  C  G  T  A  T  G  G  C  T  C  A  A  C  T  T  C-
G  A  T  T  C  A  A  G  A  G  A  T  C  G  A  A  G  T  T  G  A  G  C  C  A  T  A  C  G  G  C  T  T  T  T  T  T  A  A  G  C  T  T  G  -3′ and 
5′-A  A  T  T  C  A  A  G  C  T  T  A  A  A  A  A  A  G  C  C  G  T  A  T  G  G  C  T  C  A  A  C  T  T  C  G  A  T  C  T  C  T  T  G  A  A  T-
C  G  A  A  G  T  T  G  A  G  C  C  A  T  A  T  G  G  C  G  -3′) and siRNA2 primers (5′-G  A  T  C  C  G  A  C-
C  T  T  T  G  G  C  T  C  T  T  C  A  G  A  G  A  T  T  C  A  A  G  A  G  A  T  C  T  C  T  G  A  A  G  A  G  C  C  A  A  A  G  G  T  C  T  T  T  T-
T  T  A  A  G  C  T  T  G  -3′ and 5′-A  A  T  T  C  A  A  G  C  T  T  A  A  A  A  A  A  G  A  C  C  T   T  T  G  G  C  T  C  T  T  C-
G  A  G  A  G  T  C  T  C  T  T  G  A  A  T  C  T  C  T  G  A  A  G  A  G  -3′) were used for synthesis of double-
stranded DNA (Invitrogen). The double-stranded DNA was   ligated into 
linearized RNAi-Ready pSIREN-RetroQ-zsGreen vector   (Clontech Labora-
tories, Inc.) for producing siRNA in transfected cells. The target sequence 
of the control siRNA was the DNA sequence G  A  T  C      C  G  T  G  C  G  T  T  G  C  T  A  G  T  A-
C  C  A  A  C  T  T  C  A  A  G  A  G  A  T  T  T  T  T  T  C  G  C  G  T  G  .
Microarray analysis
Total RNAs extracted from MECs treated with BMP2 or BMP6 for 4 h or 
from mock-treated controls were processed for microarray analysis (Ren et al., 
2007). Cluster analysis and visualization using Java-TreeView were ac-
complished as previously described (Ren et al., 2007). Selected genes 
were validated by RT-PCR. The complete MIAME-compliant dataset is avail-
able at the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/ 
projects/geo/query/acc.cgi; search GSE4909).
Immunoprecipitation and Western blotting analysis
Cells were harvested in lysis buffer (1% Triton X-100, 50 mM Tris, pH 7.4, 
150 mM NaCl, 1 mM Na3VO4, and 0.1% protease inhibitor mixture; 
Sigma-Aldrich) and clariﬁ  ed by centrifugation at 16,000 g. Equal amounts 
of proteins were incubated with a speciﬁ  c antibody overnight at 4°C with 
gentle rotation. Protein A/G Plus agarose beads (Santa Cruz Biotechnol-
ogy, Inc.) were used to pull down the antibody complexes. Afterward, 
beads were washed with lysis buffer, and immune complexes were   separated 
Figure 8.  Schematic model for Myo10 as a sensor for ﬁ  lopodia to sense 
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by SDS-PAGE. Total cell lysates were separated by SDS-PAGE and trans-
ferred to nitrocellulose membranes.
Immunoﬂ  uorescence
Cells were ﬁ  xed in 3.7% PFA for 10 min at room temperature. After three 
washes with PBS, the cells were sequentially treated with 0.2% Triton 
X-100 for 5 min (for permeabilization), with 5% boiled serum for 1 h (for 
blocking), and then with the primary antibody overnight in the blocking 
  solution. After three washes, cells were incubated in the dark with second anti-
body and/or phalloidin conjugated with AlexaFluor488 or 594 (Invitrogen) 
in blocking solution for 90 min at 37°C. After three washes in PBS, the 
cells were counterstained with DAPI, and the ﬂ  uorescent signal was visual-
ized by a ﬂ  uorescence microscope or confocal laser-scanning microscope 
(LSM5 Pascal; Carl Zeiss, Inc.).
SEM experiments
The experiments were performed as previously described (Bohil et al., 
2006). Cells grown on coverslips were rinsed brieﬂ  y with PBS, preﬁ  xed 
with 3.7% PFA for 5 min, and rinsed three times with PBS. To identify and 
record the positions of individual transfected cells, the coverslips were im-
aged with ﬂ  uorescence by using an inverted microscope (DMIRB; Leica) 
and a 10× 0.75 NA dry lens. Coverslips were then prepared for SEM 
by using standard procedures, SEM images of the transfected cells were 
taken, and ﬁ  lopodia were counted. Filopodia were deﬁ  ned as thin (<1 μm 
wide) protrusions that extended at least 0.75 μm from the cell margin.
Dunn chamber assay
MECs were seeded on 50 μg/ml collagen–coated coverslips and starved 
for 18 h before assay. To set up gradient experiments, both concentric wells 
of the chamber were ﬁ  lled with starvation medium (DME with 1% FBS), and 
a coverslip seeded with cells was inverted onto the chamber in an offset 
position, leaving a narrow slit at one edge for reﬁ  lling the outer well. 
The coverslip was sealed in place using hot wax mixture around all of the 
edges except for the ﬁ  lling slit. The medium of the outer well was drained 
and replaced with medium containing 1% FBS and 200 ng/ml BMP6. 
The slit was then sealed with hot wax mixture. For control experiments in 
which cells were subjected to uniform concentrations of chemoattractant, 
both wells were ﬁ  lled with medium containing 0 or 200 ng/ml BMP6. At the 
end of each migration assay, guidemarks were drawn on the coverslip to 
mark the limits of the Dunn chamber annular bridge. All of the cells within 
the annular bridge were processed for confocal microscopy analysis (LSM5 
Pascal; Carl Zeiss, Inc.) with a 63× oil objective (Carl Zeiss, Inc.). The cells 
within the inner well and outer well served as internal controls.
Boyden chamber assay
Boyden chamber assay was performed as previously described (Ren et al., 
2007). The Boyden chamber is a 48-well chamber apparatus (Neuro-
Probe). The lower chambers of the apparatus were ﬁ  lled with DME with or 
without BMP6 and were covered with the collagen-coated ﬁ  lter and the up-
per chambers. Cells pretreated with or without BMP6 were then added to 
the upper chambers. After incubating for 6 h at 37°C, cells present on the 
lower surface were ﬁ  xed, stained, and identiﬁ  ed with the 40× objective 
lens on an inverted microscope (Eclipse TS100; Nikon).
Wound-healing assay
For detection of cell migration, a wound-healing assay was performed as 
previously described (Pi et al., 2005). MECs were grown on 35-mm wells, 
the monolayer was scratched with a sterile disposable rubber policeman, 
and the edge was labeled with a traced line. After injury, the cells were 
gently washed with normal medium without serum. Endothelial cell migra-
tion from the edge of the injured monolayer was quantiﬁ  ed by measuring 
the area between the wound edges before and the recovered area after in-
jury using light microscopy (Eclipse TS100; Nikon), a 4× objective, and 
the computer program ImageJ (National Institutes of Health).
In vitro matrigel angiogenesis assay
Endothelial cell tube formation was analyzed with the matrigel-based tube 
formation assay (Pi et al., 2005; Ren et al., 2007). Chilled 24-well plates 
were coated with growth factor–reduced matrigel (Becton Dickinson) that 
was polymerized at 37°C for 30 min. MECs were transfected with siRNA 
constructs with Lipofectamine-Plus reagents. The next day, cells were serum 
starved for 1 h, trypsinized, and plated at equal numbers into each matrigel-
coated well. After 6 h of incubation in the absence or presence of BMP6, 
the formation of tubes was photographed with a camera (Eclipse TS100; 
Nikon) and a 10× objective. Images were quantiﬁ  ed with ImageJ.
Angiogenesis assay in 3D collagen gel
A solution of rat type I collagen was prepared by mixing collagen solution 
with 5× PBS and neutralization buffer in distilled water according to the 
manufacturer’s suggestion (Chemicon). MECs suspended in DME were 
diluted in the collagen gel to a ﬁ  nal density of 2 × 105 cells ml
−1. To form 
the gel, 0.5 ml of the MEC/collagen mixture was plated per well in an un-
coated 24-well plate. BMP6 was added to the MEC/collagen mixture be-
fore collagen polymerization. After the collagen was allowed to polymerize 
for 20 min at 37°C, the gels were overlaid with 0.5 ml DME supplemented 
with BMP6 or control. Tube formation was observed at 24 h and analyzed 
with ImageJ.
Statistical analysis
Data were shown as mean ± SD for three to four separate experiments. 
Differences were analyzed with a t test. Values of P < 0.05 were consid-
ered statistically signiﬁ  cant.
Online supplemental material
Video 1 shows live cell imaging of GFP-tagged ALK6 translocating from 
cell body to ﬁ  lopodia in an MEC treated with BMP6 for 4 h. Video 2 shows 
live cell imaging of the movement of GFP-tagged Myo10 and RFP-tagged 
ALK6 in the ﬁ  lopodia of MECs. Fig. S1 shows how Myo10 knockdown with 
siRNA inhibits BMP6-directed migration of MECs pretreated with BMP6 
and VEGF but not with SIP or FGF-2. Fig. S2 shows how Myo10 knock-
down with siRNA inhibits BMP6-induced random migration in endothelial 
cells. Fig. S3 shows micrographs highlighting structural details associated 
with tube formation by MECs cultured in collagen gel in the presence of 
BMP6 treatment. Table S1 presents data on endothelial random migration 
parameters after BMP6 treatment. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200704010/DC1.
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